The Potential Drug-drug Interaction and Potential Drug-drug Interaction Evidence Ontology

Other names: DIDEO, Drug Interaction and Evidence Ontology

A domain ontology for potential drug-drug interactions (PDDIs) that covers the material entities and processes in the domain of discourse for PDDI evidence and knowledge claims. The representation enables the integration of drug interaction mechanisms, effects, risk factors, severity, and management options with the chemical and pharmacological properties (e.g., chemical structure, function, pharmacokinetic and pharmacodynamic properties) of the interacting drugs. It also has a rich and detailed set evidence entities related to pharmacology. See below for publications about DIDEO. A description of the goals of the project can be found in the following workshop paper located in the docs/DIDEO-discussion-ICBO-Brochhausen-2014.pdf: Brochhausen, M., Schneider, J., Malone, D., Empey, PE., Hogan WR., and Boyce, RD. Towards a foundational representation of potential drug-drug interaction knowledge. The 1st International Drug-Drug Interaction Knowledge Representation Workshop (DIKR 2014). Collocated with the 2014 International Conference on Biomedical Ontology (ICBO 2014). October 6th, Houston, Texas. United States.


Name: Creative Commons Attribution 4.0 International (CC BY 4.0)



drug interaction evidence natural product

More to explore:


Need help integrating and/or managing biomedical data?